Invention Grant
- Patent Title: AADC polynucleotides for the treatment of parkinson's disease
-
Application No.: US15524986Application Date: 2015-11-05
-
Publication No.: US10335466B2Publication Date: 2019-07-02
- Inventor: Robert Kotin , Adrian Philip Kells , Bernard Ravina
- Applicant: VOYAGER THERAPEUTICS, INC.
- Applicant Address: US MA Cambridge
- Assignee: VOYAGER THERAPEUTICS, INC.
- Current Assignee: VOYAGER THERAPEUTICS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: DT Ward, PC
- Agent Donna T. Ward; Mark J. Hanson
- International Application: PCT/US2015/059201 WO 20151105
- International Announcement: WO2016/073693 WO 20160512
- Main IPC: A61K35/76
- IPC: A61K35/76 ; A61P25/14 ; A61P25/16 ; C12N15/86 ; C12N9/00 ; C12N9/88 ; A61K38/51 ; A61K48/00 ; C12N7/00
Abstract:
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.
Public/Granted literature
- US20170333538A1 AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE Public/Granted day:2017-11-23
Information query
